SHP-1/STAT3-related signaling pathway in HCC targeting therapy
博士 === 國立臺灣大學 === 分子醫學研究所 === 100 === Abstract Human hepatocellular carcinoma (HCC) is the fifth most prevalent solid tumor in the world and the fourth main inducer of cancer-related death. Surgical resection, the only curative treatment for HCC, is feasible in only 20-30% of the patients at diagn...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2012
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/42324989648663549290 |